Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 5
2021 6
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean haibin chen (180 results)?
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049).
Zhou R, Qiu B, Xiong M, Liu Y, Peng K, Luo Y, Wang D, Liu F, Chen N, Guo J, Zhang J, Huang X, Rong Y, Liu H. Zhou R, et al. Among authors: chen n. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):387-399. doi: 10.1016/j.ijrobp.2023.04.021. Epub 2023 Apr 25. Int J Radiat Oncol Biol Phys. 2023. PMID: 37100160 Clinical Trial.
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059).
Ai X, Zhang P, Xie X, Qiu B, Zhu Y, Zhao L, Xi M, Wu Y, Guo S, Guo J, Liu F, Wang D, Chen N, He Q, Hu Y, Liu M, Ding Z, Liu H. Ai X, et al. Among authors: chen n. Cancer Med. 2023 Jul;12(14):15000-15010. doi: 10.1002/cam4.6136. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37326436 Free PMC article. Clinical Trial.
Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients.
Wang D, Qiu B, Liu Q, Xia L, Liu S, Zheng C, Liu H, Mo Y, Zhang X, Hu Y, Zheng S, Zhou Y, Fu J, Chen N, Liu F, Zhou R, Guo J, Fan W, Liu H. Wang D, et al. Among authors: chen n. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3400-3413. doi: 10.1007/s00259-023-06298-x. Epub 2023 Jun 13. Eur J Nucl Med Mol Imaging. 2023. PMID: 37310427
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model.
Ai X, Qiu B, Zhou Y, Li S, Li Q, Huan J, Li J, Hu N, Chen N, Liu F, Wang D, Chu C, Wang B, Chen L, Jiang H, Huang S, Huang X, Bi N, Liu H. Ai X, et al. Among authors: chen n. Radiother Oncol. 2022 Feb;167:34-41. doi: 10.1016/j.radonc.2021.11.033. Epub 2021 Dec 7. Radiother Oncol. 2022. PMID: 34890734
Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043).
Liu F, Qiu B, Xi Y, Luo Y, Luo Q, Wu Y, Chen N, Zhou R, Guo J, Wu Q, Xiong M, Liu H. Liu F, et al. Among authors: chen n. Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):433-443. doi: 10.1016/j.ijrobp.2022.07.009. Epub 2022 Jul 21. Int J Radiat Oncol Biol Phys. 2022. PMID: 35870709 Clinical Trial.
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment.
Chen NB, Xiong M, Zhou R, Zhou Y, Qiu B, Luo YF, Zhou S, Chu C, Li QW, Wang B, Jiang HH, Guo JY, Peng KQ, Xie CM, Liu H. Chen NB, et al. Radiat Oncol. 2022 Nov 16;17(1):184. doi: 10.1186/s13014-022-02136-w. Radiat Oncol. 2022. PMID: 36384755 Free PMC article. Clinical Trial.
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies.
Meng F, Ai X, Wang B, Zhou Y, Li S, Wang D, Liu F, Chen N, Zhou R, Guo J, Huang X, Yin S, Qiu B, Liu H. Meng F, et al. Among authors: chen n. Front Oncol. 2022 Oct 7;12:974394. doi: 10.3389/fonc.2022.974394. eCollection 2022. Front Oncol. 2022. PMID: 36276120 Free PMC article.
22 results